Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
QIFENG
873169
5
LAISAI LASER
871263
CN Stock MarketDetailed Quotes
002370 Zhejiang Yatai Pharmaceutical
- 3.17
- -0.08-2.46%
Not Open May 9 15:00 CST
2.36BMarket Cap81.28P/E (TTM)
3.26High3.17Low185.32KlotVolume3.26Open3.25Pre Close59.20MTurnover2.49%Turnover Ratio68.91P/E (Static)745.67MShares4.3852wk High2.49P/B2.36BFloat Cap2.2152wk Low3.58Limit Up745.67MShs Float22.10Historical High2.93Limit Down2.77%Amplitude2.21Historical Low--Dividend TTM3.19Avg Price116.34KlotAsk--Div YieldTTM100Lot Size65.64KlotBid
Zhejiang Yatai Pharmaceutical Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -42.73%64.55M | -3.68%405.17M | 1.65%306.84M | 0.36%221.93M | -8.80%112.71M | 12.64%420.64M | 28.92%301.86M | 36.92%221.14M | 80.88%123.58M | 18.50%373.44M |
| Operating revenue | -42.73%64.55M | -3.68%405.17M | 1.65%306.84M | 0.36%221.93M | -8.80%112.71M | 12.64%420.64M | 28.92%301.86M | 36.92%221.14M | 80.88%123.58M | 18.50%373.44M |
| Other operating revenue | ---- | -20.48%2.96M | ---- | -24.42%1.61M | ---- | 537.57%3.72M | ---- | 25,141.21%2.12M | ---- | -75.33%583.63K |
| Total operating cost | -38.07%70.88M | -11.22%430.11M | -7.35%327.68M | -8.34%228.08M | -9.44%114.45M | 9.90%484.47M | 18.15%353.69M | 24.25%248.84M | 39.24%126.38M | -9.55%440.81M |
| Operating cost | -41.60%44.31M | -2.37%278.89M | 5.75%211.42M | 6.92%151.27M | -1.77%75.88M | 19.10%285.65M | 31.48%199.92M | 38.89%141.48M | 84.90%77.24M | 22.52%239.83M |
| Operating tax surcharges | -2.16%1.19M | 4.02%6.39M | -7.54%4.65M | -13.79%2.96M | -24.27%1.22M | 14.04%6.14M | 20.80%5.03M | 24.84%3.44M | 38.64%1.61M | 1.33%5.38M |
| Operating expense | -34.36%9.4M | -25.44%57.13M | -22.41%44.11M | -33.71%29.54M | -26.96%14.32M | 5.78%76.61M | 1.51%56.84M | 23.65%44.56M | -5.64%19.6M | -48.59%72.43M |
| Administration expense | 9.60%14.47M | -12.20%53.43M | -15.89%40.84M | -19.08%25.69M | 0.57%13.2M | 9.02%60.85M | 13.24%48.55M | 7.60%31.74M | 5.57%13.12M | -20.22%55.81M |
| Financial expense | -111.51%-599.07K | -41.23%19.65M | -40.20%16.41M | -41.44%11.47M | -49.00%5.2M | -18.89%33.43M | -12.28%27.45M | -8.53%19.59M | -6.06%10.2M | -12.00%41.21M |
| -Interest expense (Financial expense) | -72.40%2.46M | -35.54%30.59M | -30.84%26.37M | -31.91%17.97M | -32.04%8.93M | -9.28%47.46M | -3.05%38.13M | -0.83%26.39M | -1.89%13.14M | -8.02%52.31M |
| -Interest Income (Financial expense) | 17.53%-3.08M | 19.56%-11.3M | 34.19%-7.05M | 4.57%-6.5M | -26.25%-3.73M | -26.07%-14.05M | -32.70%-10.71M | -30.83%-6.81M | -16.37%-2.96M | -10.68%-11.14M |
| Research and development | -54.46%2.11M | -32.83%14.64M | -35.51%10.25M | -10.95%7.15M | 0.76%4.64M | -16.62%21.79M | 22.58%15.9M | -7.69%8.02M | 22.16%4.61M | -8.66%26.14M |
| Credit Impairment Loss | 4.49%420.87K | 94.87%-32.19K | 108.86%83.84K | 119.30%148.42K | 233.57%402.79K | 67.76%-628.11K | -108.52%-946.79K | -13.13%-768.96K | -163.68%-301.55K | -126.45%-1.95M |
| Asset Impairment Loss | -171.70%-2.37M | 26.46%-5.56M | 65.41%-1.87M | 65.41%-1.87M | 69.02%-872.54K | 84.11%-7.57M | 11.57%-5.4M | -26.71%-5.4M | -28.16%-2.82M | 31.92%-47.61M |
| Other net revenue | -14.18%-1.67M | 14,197.84%53.09M | 595.54%17.64M | 415.27%11.31M | -312.60%-1.47M | 100.75%371.34K | 113.47%2.54M | 75.84%-3.59M | 109.42%689.5K | -81.42%-49.21M |
| Fair value change income | -1.09%-1.41M | -7.96%1.64M | -70.59%1.05M | -7,502.84%-2.77M | -141.09%-1.39M | 110.28%1.78M | 120.75%3.56M | 100.33%37.36K | 156.76%3.39M | -193.60%-17.32M |
| Invest income | ---- | 2,545.60%53.82M | 665.18%15.85M | 921.79%14.68M | ---- | 218.45%2.03M | --2.07M | --1.44M | ---- | -89.21%638.78K |
| -Including: Investment income associates | ---- | --13.86M | --13.86M | --13.86M | ---- | ---- | ---- | ---- | ---- | ---- |
| Asset deal income | ---- | -101.86%-7.37K | ---- | ---- | ---- | 1,015.36%395.07K | -60.61%13.95K | --13.95K | ---- | -99.59%35.42K |
| Other revenue | 323.83%1.69M | -25.57%3.24M | -22.03%2.53M | 1.99%1.11M | -4.42%397.56K | -74.36%4.36M | -32.83%3.24M | -15.61%1.09M | 9.98%415.94K | 605.33%16.99M |
| Operating profit | -149.56%-8M | 144.37%28.16M | 93.50%-3.2M | 116.52%5.17M | -52.11%-3.21M | 45.57%-63.45M | 41.35%-49.29M | 41.64%-31.29M | 92.92%-2.11M | 41.52%-116.57M |
| Add:Non operating Income | --1.42K | -77.99%11.44M | -99.77%122.29K | -99.78%115K | ---- | 38,001.69%51.96M | 51,213.15%52.11M | 65,103,646.75%52.08M | ---- | 3,519.03%136.38K |
| Less:Non operating expense | --11.42K | 6,702.94%5.11M | -78.25%222.36K | -78.25%222.36K | ---- | -99.60%75.11K | 5,757.38%1.02M | 412,174.53%1.02M | --1.39K | -23.95%18.88M |
| Total profit | -149.87%-8.01M | 398.22%34.49M | -284.12%-3.3M | -74.41%5.06M | -52.01%-3.21M | 91.45%-11.56M | 102.14%1.79M | 136.88%19.77M | 92.91%-2.11M | 39.63%-135.32M |
| Less:Income tax cost | -1.09%-211.34K | -21.57%245.71K | -70.59%156.88K | -7,502.86%-414.84K | -141.09%-209.06K | 111.92%313.29K | 120.75%533.4K | 100.33%5.6K | 156.76%508.79K | -163.83%-2.63M |
| Net profit | -160.25%-7.8M | 388.29%34.24M | -374.48%-3.46M | -72.30%5.48M | -14.49%-3M | 91.05%-11.88M | 101.55%1.26M | 138.06%19.77M | 90.93%-2.62M | 41.87%-132.69M |
| Net profit from continuing operation | -160.25%-7.8M | 388.29%34.24M | -374.48%-3.46M | -72.30%5.48M | -14.49%-3M | 91.05%-11.88M | 101.55%1.26M | 138.06%19.77M | ---2.62M | 41.87%-132.69M |
| Net profit of parent company owners | -160.25%-7.8M | 388.29%34.24M | -374.48%-3.46M | -72.30%5.48M | -14.49%-3M | 91.05%-11.88M | 101.55%1.26M | 138.06%19.77M | 90.93%-2.62M | 41.87%-132.69M |
| Earning per share | ||||||||||
| Basic earning per share | -114.29%-0.0105 | 350.00%0.05 | -343.48%-0.0056 | -75.00%0.01 | 0.00%-0.0049 | 92.00%-0.02 | 101.52%0.0023 | 140.00%0.04 | 90.89%-0.0049 | 41.86%-0.25 |
| Diluted earning per share | -114.29%-0.0105 | 350.00%0.05 | -343.48%-0.0056 | -75.00%0.01 | 0.00%-0.0049 | 92.00%-0.02 | 101.52%0.0023 | 140.00%0.04 | 90.89%-0.0049 | 41.86%-0.25 |
| Other composite income | 598.38K | 598.38K | 598.38K | |||||||
| Other composite income of parent company owners | ---- | --598.38K | --598.38K | --598.38K | ---- | ---- | ---- | ---- | ---- | ---- |
| Total composite income | -160.25%-7.8M | 393.33%34.84M | -327.01%-2.86M | -69.27%6.07M | -14.49%-3M | 91.05%-11.88M | 101.55%1.26M | 138.06%19.77M | 90.93%-2.62M | 41.87%-132.69M |
| Total composite income of parent company owners | -160.25%-7.8M | 393.33%34.84M | -327.01%-2.86M | -69.27%6.07M | -14.49%-3M | 91.05%-11.88M | 101.55%1.26M | 138.06%19.77M | 90.93%-2.62M | 41.87%-132.69M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | ZTE Caiguanghua Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | ZTE Caiguanghua Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | ZTE Caiguanghua Certified Public Accountants Co., Ltd. (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting